Tech Tuesday – etectRx

Tech Tuesday with Eric Buffkin, CEO of etectRx, as he outlines the company's newest partnership with the Village in Gainesville to improve incontinence monitoring, elevate care for seniors, and alleviate pressure on staff.

Why Aren’t Digital Pills Taking Off?

In 2017, the US Food and Drug Administration (FDA) broke ground by approving the first drug with an embedded biosensor to track its use. The enthusiasm for digital approaches involving sensors, apps, and wearables that could transmit information across systems, commonly grouped under the term Internet of Things, also spread. Yet, despite the landmark FDA approval, digital pills have not exploded in pharma. Privacy and logistical concerns, especially while studying such applications for vulnerable populations, have lingered.

Medication Safety 2.0: Advances in Adherence Technology

A recently published review on emerging smart technology innovations in the health care sector suggests various advanced technologies and methods may now significantly improve medication adherence.1 Two significant advances have been the ability to measure medication adherence and safety issues with medication event monitoring systems (MEMS) and smart blister packs containing radio frequency identification technology.

DTx Company Pear Inks Deal with etectRx

The etectRx partnership will focus on medication adherence. Pear will now be able to integrate etectRx's digital pill, which can show if a patient ingested the medication.

Pear, etectRx To Explore Use of Sensors To Help Patients Stick With Digital Therapeutics

Pear Therapeutics is teaming up with UF Innovate | The Hub startup etectRx in a "first of its kind" collaboration examining the use of digital pill solutions with prescription digital therapeutics (PDTs), the latter company announced. As part of the agreement, whose financial terms were not disclosed, the companies will work on developing up to two central nervous system product candidates combining PDTs and adherence sensors.